KONSTANTIN "Gus" KOUSOULAS

About KONSTANTIN "Gus" KOUSOULAS

KONSTANTIN "Gus" KOUSOULAS, With an exceptional h-index of 53 and a recent h-index of 23 (since 2020), a distinguished researcher at Louisiana State University, specializes in the field of Virology, cancer biology, gene therapy, vaccines.

His recent articles reflect a diverse array of research interests and contributions to the field:

Oncolytic hsv-1 (vc2) gm-csf regulates the proinflammatory profile suggestive of an immunomodulatory effect in PDAC cells

Herpes simplex virus type 1 derived influenza vaccine

Guinea pig herpes like virus is a gamma herpesvirus

Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice

Spike protein vaccine triggers systemic Th2 and Th17 inflammatory responses and pulmonary immunopathology following SARS-CoV-2 breakthrough infection

176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice

Effect of stimulator of interferon genes (STING) signaling on radiation-induced chemokine expression in human osteosarcoma cells

Inactivation of the UL37 Deamidase Enhances Virus Replication and Spread of the HSV-1 (VC2) Oncolytic Vaccine Strain and Secretion of GM-CSF

KONSTANTIN "Gus" KOUSOULAS Information

University

Position

Professor of Virology and Biotechnology

Citations(all)

7499

Citations(since 2020)

2598

Cited By

5664

hIndex(all)

53

hIndex(since 2020)

23

i10Index(all)

127

i10Index(since 2020)

76

Email

University Profile Page

Google Scholar

KONSTANTIN "Gus" KOUSOULAS Skills & Research Interests

Virology

cancer biology

gene therapy

vaccines

Top articles of KONSTANTIN "Gus" KOUSOULAS

Oncolytic hsv-1 (vc2) gm-csf regulates the proinflammatory profile suggestive of an immunomodulatory effect in PDAC cells

Cancer Research

2024/3/22

Herpes simplex virus type 1 derived influenza vaccine

2024/2/15

Guinea pig herpes like virus is a gamma herpesvirus

Virus Genes

2024/2/10

Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice

Journal of Medical Virology

2024/1

Spike protein vaccine triggers systemic Th2 and Th17 inflammatory responses and pulmonary immunopathology following SARS-CoV-2 breakthrough infection

The Journal of Immunology

2023/5/1

176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice

Journal of Investigative Dermatology

2023/5/1

Effect of stimulator of interferon genes (STING) signaling on radiation-induced chemokine expression in human osteosarcoma cells

Plos one

2023/4/20

Inactivation of the UL37 Deamidase Enhances Virus Replication and Spread of the HSV-1 (VC2) Oncolytic Vaccine Strain and Secretion of GM-CSF

Viruses

2023/1/27

Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation

Frontiers in immunology

2023/1/18

Unlocking the potential of kinase targets in cancer: insights from CancerOmicsNet, an AI-driven approach to drug response prediction in cancer

Cancers

2023/8/10

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro …

Frontiers in Molecular Biosciences

2023/6/14

Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors

BMC cancer

2022/11/24

Activating transcription factor 6 protects against endothelial barrier dysfunction

Cellular signalling

2022/11/1

Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G

Vaccine

2022/10/6

Predicted Structure and Functions of the Prototypic Alphaherpesvirus Herpes Simplex Virus Type-1 UL37 Tegument Protein

Viruses

2022/10/4

Vaccines against genital herpes simplex infections

2022/8/4

Oncolytic virotherapy with the HSV-1 (VC2) vaccine strain induces anti-tumor T-cell responses in the murine 4T1 breast cancer model

Cancer Research

2022/6/15

Prospects for personalized cancer vaccines: The oncolytic and immunotherapeutic HSV-1 (VC2) virus expressing an ovalbumin (OVA) antigen elicits robust anti-OVA immune responses

Cancer Research

2022/6/15

An attenuated HSV-1-derived malaria vaccine expressing liver-stage exported proteins induces sterilizing protection against infectious sporozoite challenge

Vaccines

2022/2/16

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines

Frontiers in molecular biosciences

2022/1/26

See List of Professors in KONSTANTIN "Gus" KOUSOULAS University(Louisiana State University)

Co-Authors

academic-engine